olopatadine hydrochloride and mometasone furoate

FDA Drug Profile — Ryaltris

Drug Details

Generic Name
olopatadine hydrochloride and mometasone furoate
Brand Names
Ryaltris
Application Number
NDA211746
Sponsor
HIKMA SPECIALTY USA INC.
NDC Codes
2
Dosage Forms
SPRAY, METERED
Routes
NASAL
Active Ingredients
MOMETASONE FUROATE MONOHYDRATE, OLOPATADINE HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE RYALTRIS is indicated for the treatment of symptoms of seasonal allergic rhinitis in adult and pediatric patients 12 years of age and older. RYALTRIS is a combination of olopatadine, a histamine-1 (H1)-receptor inhibitor, and mometasone furoate, a corticosteroid, indicated for the treatment of symptoms of seasonal allergic rhinitis in adult and pediatric patients 12 years of age and older. ( 1 )